Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Minerva Gastroenterology|November 20, 2025
The molecular basis of sarcopenia in inflammatory bowel disease: from gut-muscle axis to therapeutic opportunitiesSara Troisi, Guglielmo Sicilia, Valentina Petito, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 26, 2014
Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD)Marco Daperno, Michele Comberlato, Fabrizio Bossa, et al.
Biomed Research International|September 25, 2013
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agentsLuisa Guidi, Carla Felice, Annabella Procoli, et al.
Radiology|December 14, 2011
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activityAntonio De Franco, Alessandra Di Veronica, Alessandro Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2013
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic miceLoris Riccardo Lopetuso, Valentina Petito, Valerio Cufino, et al.
Inflammatory Bowel Diseases|July 2, 2014
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitisAlessandro Armuzzi, Daniela Pugliese, Silvio Danese, et al.
World Journal of Gastroenterology|December 14, 2016
Infliximab does not increase colonic cancer risk associated to murine chronic colitisLoris R Lopetuso, Valentina Petito, Tiziano Zinicola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 26, 2016
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of actionValentina Petito, Loris Riccardo Lopetuso, Vincenzo Arena, et al.
United European Gastroenterology Journal|November 9, 2019
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel diseaseLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.
Minerva Gastroenterology|March 19, 2026
Modulation of IL33/ST2 axis and mucosal healing in IBD: state of the art and future perspectivesGreta Migliore, Sara Troisi, Valentina Petito, et al.
Pageof 13